T/R potency <5% [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2022-09-09 19:08 (197 d 03:04 ago) – Posting: # 23286
Views: 1,221

Hi Achievwin,

❝ It is not about potency correction, it is about controlling errors wherever possible …


❝ I believe I heard (in the 2000 BE workshop) rationale for this 5% difference is to accomodate aging differences (time of manufacture to time of dosing) between Test and RLD (usually RLD is older than Test …

Which workshop? Let’s compile what we have:

❝ … and also assay variabilities (Damn: everyone blames poor analytical chemist :confused::confused:).

That’s the point. What are the batch release spec’s? Generally ±10% and for NTIDs ±5%. Of course, you don’t get a CoA from the originator. Analyzing the reference with the method validated for the test is not a problem for IR. Little bit more tricky for MR. A nightmare for creams and ointments with their fantastic emulsifiers. You never can’t be sure. Yes, analytical (in)accuracy and (im)precision hits … Say, you have a great routine method with 2% and you measure a potency 100% for T and R. What are the true values? Can be <100% for T and >100% for R. That’s why in sample size estimation one should never (ever!) assume a T/R-ratio of 1.

In [image]:

T <- rnorm(n = 1e7, mean = 1, sd = 0.02)
R <- rnorm(n = 1e7, mean = 1, sd = 0.02)
round(quantile(T / R, probs = c(0.025, 0.5, 0.975)), 4)
 2.5%   50% 97.5%
0.946 1.000 1.057

That’s why in most sample size functions of PowerTOST 0.95 is the default.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
 Admin contact
22,551 posts in 4,724 threads, 1,606 registered users;
17 visitors (0 registered, 17 guests [including 7 identified bots]).
Forum time: 21:13 CET (Europe/Vienna)

If there is an exception to any rule,
and if it can be proved by observation,
that rule is wrong.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz